Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein.
Joint Bone Spine(2014)
摘要
Erdheim-Chester disease is a rare non-langerhans systemic histiocytosis of unknown origin, associated with bone diseases and severe visceral complications. Therapies have been disappointing. A recombinant form of interleukin-1 receptor antagonist (anakinra) has been used in a few cases when usual treatment fails. We report a new case of successfully interleukin-1 receptor antagonist treatment in Erdheim-Chester disease.
更多查看译文
关键词
Erdheim-Chester disease,Histiocytosis,Interleukin-1 receptor antagonist protein,Anakinra
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要